Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
2007 (English)In: NeuroReport, ISSN 0959-4965, E-ISSN 1473-558X, Vol. 18, no 6, 559-563 p.Article in journal (Refereed) Published
Aggregation of the amyloid-beta (Abeta) peptide into amyloid plaques is a characteristic feature of Alzheimer's disease neuropathogenesis. We and others have previously demonstrated delayed Abeta aggregation as a consequence of oxidizing a single methionine residue at position 35 (Met-35). Here, we examined the consequences of Met-35 oxidation on the extremely aggregation-prone peptides Abeta1-42 and Abeta1-40Arctic with respect to protofibril and oligomer formation as well as neurotoxicity. Size exclusion chromatography and mass spectrometry demonstrated that monomer/dimers prevailed over larger oligomers after oxidizing Met-35, and consequently protofibril formation and aggregation of both Abeta1-42 and Abeta1-40Arctic were delayed. The oxidized peptides completely lacked neurotoxic effects in cortical neuronal cultures under these conditions, in contrast to the neurotoxic properties of the unoxidized peptides. We conclude that oxidation of Met-35 significantly attenuates aggregation of Abeta1-42 and Abeta1-40Arctic, and thereby reduces neurotoxicity.
Place, publisher, year, edition, pages
2007. Vol. 18, no 6, 559-563 p.
amyloid-b, methionine 35, neurotoxicity, oligomers, oxidation, protofibrils
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-95578ISI: 000245609300007PubMedID: 17413657OAI: oai:DiVA.org:uu-95578DiVA: diva2:169854